BioInvest In The News

Wide World of Stocks (4-9-15)
MoneyShow: A Trio of Biotech Favorites (4-6-15)
Wide World of Stocks (3-16-15)
MarketWatch (2-26-15)
Forbes (2-25-15)
The Money Show (2-25-15)
Company Updates
Medicines Company Update (4-9-15)

Medicines Company Update (4-9-15)

Special Update – The Medicines Company (MDCO) – Angiomax Pre-Announcement Now Discounts Patent Loss – The Reincarnation Is Around The Corner. Q1 Angiomax Shortfall Not Entirely Unexpected. In our last Issue, we mentioned that based upon the judge’s comments from the March trial, Hospira is very optimistic that they will win the Angiomax patent lawsuit. read more…

Ziopharm Update (4-2-15)

Ziopharm Update (4-2-15)

ZIOP/XON Form Solid Partnerships With Merck KgaA & NCI CAR-T Superstar Rosenberg for Solid Tumors – ZIOP’s partner Intrexon (XON) has delivered two more exciting partnerships that ZIOP receives 50% of all assets and economics. The fact that the deals were both primarily announced by XON has caused a bit of confusion. For example, …

Anthera Update (3-17-15)

Anthera Update (3-17-15)

      Special Update – Anthera (ANTH) – Raising TARGET PRICE to 25 IgAN Positive Interim Look Is Second Straight For B-Mod Update With Management Confirms Improving Fundamentals Stock Sell Off Unwarranted; $92m. mkt cap & 3 Phase IIIs Raising TARGET PRICE to 25 B-Mod IgAN Passes Futility Check – Anthera delivered another positive interim [...]